Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Infant Bacterial Therapeutics AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 More Arrow 277
Earnings before taxes -141,190 More Arrow -124,670 More Arrow -61,911
EBITDA -149,892 More Arrow -136,371 More Arrow -62,249
Total assets 247,064 More Arrow 355,912 Less Arrow 330,709
Current assets 237,828 More Arrow 346,014 Less Arrow 320,694
Current liabilities 71,472 Less Arrow 46,782 Less Arrow 16,944
Equity capital 175,592 More Arrow 309,131 More Arrow 313,765
- share capital 3,787 Less Arrow 3,720 Less Arrow 2,894
Employees (average) 10 Less Arrow 8 Less Arrow 7

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 71.1% More Arrow 86.9% More Arrow 94.9%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -57.1% More Arrow -35.0% More Arrow -18.6%
Current ratio 332.8% More Arrow 739.6% More Arrow 1892.7%
Return on equity (ROE) -80.4% More Arrow -40.3% More Arrow -19.7%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 Less Arrow 1 Less Arrow -1
Chg. No. of employees % 25% Less Arrow 14% Less Arrow -13%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.